Granules India shareholding pattern

·Pharma & Health Chart ›

Who owns itSep 2026 quarter

Promoters37.39%no change

Foreign investors (FII)20.25%−0.04 pts

Domestic institutions (DII)15.33%−0.07 pts

of which mutual funds4.26%+0.08 pts

of which insurance companies6.94%

Public27.04%

Per cent of all shares; change on the Sep 2026 quarter, in percentage points. As filed with the exchanges.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

GRANULES₹840.45

Granules India Ltd.

· Pharma & Health

₹ CrorePeersAUROPHARMA IPCALAB AARTIDRUGS ERIS INDGN EMCURE JUBLPHARMA CONCORDBIOMcap ₹20,826 Cr

Holding % of Total Shares 12 Months Ending	Q2 FY25 30/09/2024	Q3 FY25 31/12/2024	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026	Q2 FY27 16/09/2026	Q2 FY27 30/09/2026
Promoter & Group	38.87	38.85	38.84	38.82	38.82	38.82	38.02	38.02	37.39	37.39
FII / FPI	19.49	15.87	15.15	—	14.09	13.55	15.31	17.50	20.29	20.25
DII	14.87	19.57	22.45	—	17.92	17.48	17.01	16.11	15.40	15.33
Mutual Funds	7.86	10.39	11.57	—	6.54	5.35	2.85	3.45	4.18	4.26

Latest: 2026-09-30 · 66 quarters of history · click a row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.